Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,170.31 -9.37 (-0.11%) Bitcoin USD
60,699.11 -1,018.71 (-1.65%) CMC Crypto 200
1,269.36 -14.47 (-1.13%)
Newland Pharmaceutical Co., Ltd. (301277.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 3.61B |
| Enterprise value | 2.75B |
| Trailing P/E | 21.47 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.45 |
| Price/book (mrq) | 2.40 |
| Enterprise value/revenue | 4.14 |
| Enterprise value/EBITDA | 14.58 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -7.58% |
| S&P500 52-week change 3 | 23.20% |
| 52-week high 3 | 22.49 |
| 52-week low 3 | 9.30 |
| 50-day moving average 3 | 14.36 |
| 200-day moving average 3 | 14.16 |
Share statistics
| Avg vol (3-month) 3 | 9.48M |
| Avg vol (10-day) 3 | 4.51M |
| Shares outstanding 5 | 280.06M |
| Implied shares outstanding 6 | 280.7M |
| Float 8 | 62.85M |
| % held by insiders 1 | 78.62% |
| % held by institutions 1 | 0.21% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.4 |
| Forward annual dividend yield 4 | 3.11% |
| Trailing annual dividend rate 3 | 0.29 |
| Trailing annual dividend yield 3 | 2.22% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 59.52% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 10 May 2024 |
| Last split factor 2 | 1.4:1 |
| Last split date 3 | 10 May 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 25.35% |
| Operating margin (ttm) | 30.21% |
Management effectiveness
| Return on assets (ttm) | 6.35% |
| Return on equity (ttm) | 11.41% |
Income statement
| Revenue (ttm) | 663.48M |
| Revenue per share (ttm) | 2.37 |
| Quarterly revenue growth (yoy) | 7.00% |
| Gross profit (ttm) | N/A |
| EBITDA | 199.61M |
| Net income avi to common (ttm) | 168.18M |
| Diluted EPS (ttm) | 0.60 |
| Quarterly earnings growth (yoy) | 19.70% |
Balance sheet
| Total cash (mrq) | 860.6M |
| Total cash per share (mrq) | 3.07 |
| Total debt (mrq) | 2.37M |
| Total debt/equity (mrq) | 0.16% |
| Current ratio (mrq) | 7.09 |
| Book value per share (mrq) | 5.37 |
Cash flow statement
| Operating cash flow (ttm) | 241.45M |
| Levered free cash flow (ttm) | 125.21M |
© 2024 Yahoo. All rights reserved.